KLRK1 and Miyoshi myopathy: Moreover, it has been shown that different classes of therapeutic agents upregulate DNAM-1 as well as NKG2D ligands [47, 48], thus strengthening the concept that NK cells might truly represent powerful adjuvant arms against MM.